REGN Regeneron Pharmaceuticals, Inc. - Common Stock
Informazioni su Regeneron Pharmaceuticals, Inc. - Common Stock Panoramica della società da Wikipedia
La Regeneron Pharmaceuticals, nota anche semplicemente come Regeneron, è un'azienda statunitense di biotecnologia e biofarmaceutica attiva nell'ambito della ricerca, sviluppo e commercializzazione di farmaci. Fondata nel 1988 e con sede a Tarrytown, New York, fa parte dell'indice NASDAQ-100 e S&P 500.
Leggi di più
La Regeneron Pharmaceuticals, nota anche semplicemente come Regeneron, è un'azienda statunitense di biotecnologia e biofarmaceutica attiva nell'ambito della ricerca, sviluppo e commercializzazione di farmaci. Fondata nel 1988 e con sede a Tarrytown, New York, fa parte dell'indice NASDAQ-100 e S&P 500.
Fonte: Wikipedia, CC BY-SA 4.0 · Vedi su Wikipedia ↗
REGN Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
REGN Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Dividendi Rendimento, payout ratio, storico dividendi, CAGR 5Y
| Data ex-dividendo | Importo |
|---|---|
| 18 Agosto 2026 | $0,9400 |
| 20 Maggio 2026 | $0,9400 |
| 20 Febbraio 2026 | $0,9400 |
| 20 Novembre 2025 | $0,8800 |
| 18 Agosto 2025 | $0,8800 |
| 20 Maggio 2025 | $0,8800 |
| 20 Febbraio 2025 | $0,8800 |
REGN Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
- Acquisto forte 8 21,6%
- Compra 18 48,6%
- Mantieni 11 29,7%
- Vendi 0 0,0%
- Vendita forte 0 0,0%
Target Price a 12 Mesi
27 analisti · 2026-08-19Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 30 Giugno 2026 | $14.29 | $10.47 | 3.8% |
| 31 Marzo 2026 | $9.47 | $9.12 | 0.35% |
| 31 Dicembre 2025 | $11.44 | $10.83 | 0.61% |
| 30 Settembre 2025 | $11.83 | $9.78 | 2.0% |
| 30 Giugno 2025 | $12.89 | $8.61 | 4.3% |
| 31 Marzo 2025 | $8.22 | $9.00 | -0.78% |
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| REGN | $106.21B | 18.6 | 0.99% | 31.4% | 14.7% | — |
| ABBV | — | 96.8 | 8.6% | 6.9% | 15367.3% | — |
| AMGN | $176.35B | 23.0 | 10.0% | 21.0% | 95.9% | — |
| GILD | $152.32B | 18.1 | 2.4% | 28.9% | 40.5% | — |
| VRTX | $115.15B | 29.6 | 8.9% | 32.9% | 22.1% | — |
| NTRA | $32.00B | -150.7 | 35.9% | -9.0% | -14.1% | — |
| RVMD | — | — | — | — | — | — |
| BIIB | $25.84B | 20.0 | 2.2% | 13.1% | 7.2% | — |
| ALNY | $52.64B | 170.7 | 65.2% | 8.5% | 60.4% | — |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 16
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $14.34B | $14.20B | $13.12B | $12.17B | $16.07B | $8.50B | $6.56B | $5.15B | $5.87B | $4.86B | $4.10B | $2.82B | |
| Cost of Revenue | · | · | · | · | · | · | $403M | $238M | $203M | $195M | $242M | $129M | |
| R&D Expense | $5.85B | $5.13B | $4.44B | $3.59B | $2.86B | $2.65B | $2.45B | $1.47B | $2.08B | $2.05B | $1.62B | $1.27B | |
| SG&A Expense | $2.70B | $2.95B | $2.63B | $2.12B | $1.82B | $1.35B | $1.34B | $1.13B | $1.32B | $1.18B | $839M | $519M | |
| Operating Expenses | $10.77B | $10.21B | $9.07B | $7.43B | $7.12B | $4.92B | $4.35B | $2.61B | $3.79B | $3.53B | $2.85B | $2.00B | |
| Operating Income | $3.58B | $3.99B | $4.05B | $4.74B | $8.95B | $3.58B | $2.21B | $2.53B | $2.08B | $1.33B | $1.25B | $824M | |
| Interest Expense | · | · | $73M | $59M | $57M | $57M | $30M | $28M | $25M | $7M | $14M | $37M | |
| Other Non-op | $1.70B | $844M | $225M | $179M | $436M | $291M | $250M | $47M | $24M | $6M | $-13M | $-25M | |
| Pretax Income | $5.23B | $4.78B | $4.20B | $4.86B | $9.33B | $3.81B | $2.43B | $2.55B | $2.08B | $1.33B | $1.23B | $761M | |
| Income Tax | $726M | $367M | $246M | $520M | $1.25B | $297M | $313M | $109M | $880M | $434M | $589M | $423M | |
| Net Income | $4.50B | $4.41B | $3.95B | $4.34B | $8.08B | $3.51B | $2.12B | $2.44B | $1.20B | $896M | $636M | $338M | |
| EPS (Basic) | $43.07 | $40.90 | $37.05 | $40.51 | $76.40 | $32.65 | $19.38 | $22.65 | $11.27 | $8.55 | $6.17 | $3.36 | |
| EPS (Diluted) | $41.48 | $38.34 | $34.77 | $38.22 | $71.97 | $30.52 | $18.46 | $21.29 | $10.34 | $7.70 | $5.52 | $2.98 | |
| Shares (Basic) | 104,600,000 | 107,900,000 | 106,700,000 | 107,100,000 | 105,700,000 | 107,600,000 | 109,200,000 | 107,900,000 | 106,300,000 | 104,700,000 | 103,061,000 | 100,612,000 | |
| Shares (Diluted) | 108,600,000 | 115,100,000 | 113,700,000 | 113,500,000 | 112,200,000 | 115,100,000 | 114,600,000 | 114,800,000 | 115,900,000 | 116,300,000 | 115,230,000 | 113,413,000 | |
| EBITDA | $4.12B | $4.47B | $4.47B | $5.08B | $9.23B | $3.81B | $2.42B | $2.68B | $2.23B | $1.44B | $1.33B | $891M |
Stato Patrimoniale 27
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3.12B | $2.49B | $2.73B | $3.11B | $2.89B | $2.19B | $1.62B | $1.47B | $813M | $535M | $809M | $649M | |
| Short-term Investments | $5.49B | $6.52B | $8.11B | $4.64B | $2.81B | $1.39B | $1.60B | $1.34B | $597M | $503M | $236M | $252M | |
| Receivables | $5.74B | $6.21B | $5.67B | $5.33B | $6.04B | $4.11B | $2.10B | $1.72B | $1.54B | $1.34B | $1.15B | $739M | |
| Inventory | $3.20B | $3.09B | $2.58B | $2.40B | $1.95B | $1.92B | $1.42B | $1.15B | $726M | $399M | $239M | $129M | |
| Prepaid Expense | $475M | $349M | $387M | $411M | $332M | $161M | $274M | $243M | $225M | $131M | $164M | $79M | |
| Current Assets | $18.02B | $18.66B | $19.48B | $15.88B | $14.01B | $9.78B | $7.69B | $6.45B | $4.33B | $3.18B | $2.92B | $2.08B | |
| PP&E (Net) | · | · | · | · | $3.48B | $3.22B | $2.89B | $2.58B | $2.36B | $2.08B | $1.59B | $974M | |
| PP&E (Gross) | · | · | · | · | · | · | $3.81B | $3.30B | $2.92B | $2.51B | $1.93B | $1.23B | |
| Accum. Depreciation | · | · | · | · | · | · | $922M | $729M | $566M | $426M | $331M | $254M | |
| Intangibles | $1.26B | $1.15B | $1.04B | $916M | $7M | · | · | · | · | · | · | · | |
| Other Non-current Assets | $1.82B | $1.14B | $444M | $336M | $216M | $168M | $145M | $127M | $78M | $20M | $6M | $3M | |
| Total Assets | $40.56B | $37.76B | $33.08B | $29.21B | $25.43B | $17.16B | $14.81B | $11.73B | $8.76B | $6.97B | $5.61B | $3.84B | |
| Accounts Payable | $939M | $790M | $607M | $589M | $564M | $476M | $418M | $218M | $178M | $879M | $644M | $483M | |
| Short-term Debt | · | · | · | · | · | · | $0 | · | · | · | · | · | |
| Current Liabilities | $4.37B | $3.94B | $3.42B | $3.14B | $3.93B | $2.70B | $2.10B | $1.44B | $1.14B | $1.24B | $811M | $655M | |
| Capital Leases | $229M | $204M | $69M | $56M | · | · | · | $708M | · | · | · | · | |
| Other Non-current Liabilities | $2.02B | $1.57B | $854M | $638M | $680M | $687M | $318M | $362M | $152M | $100M | $116M | $40M | |
| Total Liabilities | $9.30B | $8.41B | $7.11B | $6.55B | $6.67B | $6.14B | $3.72B | $2.98B | $2.62B | $2.52B | $1.95B | $1.29B | |
| Total Debt | $1.99B | $1.98B | $1.98B | $1.98B | $1.98B | $1.98B | · | · | · | · | · | · | |
| Common Stock | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $108.0K | $106.0K | $102.0K | |
| Paid-in Capital | $13.99B | $12.86B | $11.35B | $9.95B | $8.09B | $6.72B | $4.43B | $3.91B | $3.51B | $3.03B | $3.10B | $2.45B | |
| Retained Earnings | $35.80B | $31.67B | $27.26B | $23.31B | $18.97B | $10.89B | $7.38B | $5.25B | $2.95B | $1.75B | $853M | $217M | |
| Treasury Stock | $18.61B | $15.17B | $12.56B | $10.35B | $8.26B | $6.61B | $740M | $396M | $316M | $316M | $306M | $170M | |
| AOCI | $78M | $-8M | $-81M | $-239M | $-26M | $29M | $21M | $-12M | $600.0K | $-13M | $9M | $52M | |
| Stockholders' Equity | $31.26B | $29.35B | $25.97B | $22.66B | $18.77B | $11.03B | $11.09B | $8.76B | $6.14B | $4.45B | $3.65B | $2.55B | |
| Liabilities + Equity | $40.56B | $37.76B | $33.08B | $29.21B | $25.43B | $17.16B | $14.81B | $11.73B | $8.76B | $6.97B | $5.61B | $3.84B | |
| Shares Outstanding | 137,600,000 | 136,000,000 | 133,100,000 | 130,400,000 | 126,200,000 | 121,500,000 | 113,300,000 | · | · | · | · | · |
Flusso di cassa 19
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $544M | $483M | $421M | $341M | $286M | $236M | $210M | $148M | $146M | $105M | $75M | $53M | |
| Stock-based Comp | $994M | $983M | $885M | $725M | $602M | $432M | $464M | $427M | $507M | $560M | $459M | $322M | |
| Deferred Tax | $-785M | $-757M | $-838M | $-746M | $-147M | $76M | $-131M | $-140M | $319M | $-360M | $-130M | $-46M | |
| Amort. of Intangibles | $179M | $129M | $92M | $38M | $0 | · | · | · | · | · | · | · | |
| Other Non-cash | $-278M | $-700M | $172M | $356M | $-1.73B | $-1.64B | $-230M | $-685M | $-863M | $273M | $291M | $86M | |
| Operating Cash Flow | $4.98B | $4.42B | $4.59B | $5.01B | $7.08B | $2.62B | $2.43B | $2.20B | $1.31B | $1.49B | $1.33B | $752M | |
| CapEx | $898M | $756M | $719M | $590M | $552M | $615M | $430M | $383M | $273M | $512M | $678M | $333M | |
| Investing Cash Flow | $-629M | $-2.47B | $-3.19B | $-3.78B | $-5.38B | $-71M | $-2.03B | $-1.46B | $-1.01B | $-1.05B | $-908M | $-421M | |
| Debt Issued | · | · | · | $0 | $0 | $1.98B | $0 | $0 | · | · | · | · | |
| Net Debt Issued | · | · | · | $0 | $0 | $1.98B | · | · | · | · | · | · | |
| Stock Issued | $636M | $1.47B | $1.15B | $1.52B | $1.67B | $2.58B | $212M | $114M | $240M | $127M | $206M | $126M | |
| Stock Repurchased | $3.44B | $2.60B | $2.23B | $2.08B | $1.65B | $5.85B | $276M | $4M | $0 | $0 | · | · | |
| Net Stock Activity | $-2.80B | $-1.14B | $-1.09B | $-563M | $27M | $-3.27B | $-64M | $110M | $240M | $127M | $206M | $126M | |
| Dividends Paid | $370M | $0 | $0 | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-3.72B | $-2.20B | $-1.79B | $-1.01B | $-1.01B | $-1.97B | $-252M | $-77M | $-24M | $-700M | $-263M | $-219M | |
| Net Change in Cash | $635M | $-249M | $-382M | $221M | $691M | $577M | $150M | $655M | $278M | $-261M | $160M | $113M | |
| Taxes Paid | $1.25B | $743M | $870M | $1.50B | $1.22B | $188M | $342M | $206M | $755M | $481M | $276M | $60M | |
| Free Cash Flow | $4.08B | $3.66B | $3.88B | $4.42B | $6.53B | $2.00B | $2.00B | $1.81B | $1.03B | $961M | $653M | $410M | |
| Levered FCF | · | · | $3.81B | $4.37B | $6.48B | $1.95B | $1.97B | $1.79B | · | · | $645M | $393M |
Redditività 7
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 24.9% | 28.1% | 30.9% | 38.9% | 55.7% | 42.1% | 28.1% | 37.8% | 35.4% | 27.4% | 30.5% | 29.7% | |
| Net Margin | 31.4% | 31.1% | 30.1% | 35.6% | 50.2% | 41.3% | 26.9% | 36.4% | 20.4% | 18.4% | 15.5% | 12.3% | |
| Pretax Margin | 36.5% | 33.7% | 32.0% | 39.9% | 58.0% | 44.8% | 30.9% | 38.0% | 35.4% | 27.4% | 29.8% | 27.5% | |
| EBITDA Margin | 28.7% | 31.5% | 34.1% | 41.7% | 57.5% | 44.9% | 30.8% | 40.0% | 37.9% | 29.5% | 32.3% | 31.6% | |
| ROA | 11.5% | 12.5% | 12.7% | 15.9% | 37.9% | 22.0% | 15.9% | 23.8% | 15.2% | 14.2% | 13.5% | 10.2% | |
| ROE | 14.7% | 15.0% | 15.5% | 19.7% | 44.8% | 33.2% | 19.6% | 29.4% | 22.6% | 22.1% | 20.5% | 15.4% | |
| ROIC | 9.3% | 11.8% | 13.6% | 17.2% | 37.3% | 25.4% | 17.4% | 27.7% | 19.5% | 20.1% | 17.8% | 14.8% |
Liquidità e Solvibilità 5
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.1 | 4.7 | 5.7 | 5.1 | 3.6 | 3.6 | 3.7 | 4.5 | 3.8 | 2.6 | 3.6 | 3.3 | |
| Quick Ratio | 3.3 | 3.9 | 4.8 | 4.2 | 3.0 | 2.5 | 2.5 | 3.1 | 2.6 | 1.9 | 2.7 | 2.5 | |
| Debt / Equity | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | · | · | · | · | · | · | |
| LT Debt / Equity | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | · | · | · | · | · | · | |
| Interest Coverage | · | · | 55.4 | 79.8 | 156.1 | 62.9 | 73.2 | 89.9 | · | · | 87.9 | 22.4 |
Efficienza 3
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | 0.4 | 0.4 | 0.8 | 0.5 | 0.6 | 0.7 | 0.7 | 0.8 | 0.9 | 0.8 | |
| Inventory Turnover | · | · | · | · | · | · | · | · | 0.4 | 0.6 | 1.3 | 1.3 | |
| Receivables Turnover | 2.4 | 2.4 | 2.4 | 2.1 | 3.2 | 3.3 | 4.1 | 4.1 | 4.1 | 3.9 | 4.3 | 3.7 |
Tassi di Crescita 9
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 0.99% | 8.3% | 7.8% | -24.3% | 89.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 5.6% | -4.0% | 15.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 8.2% | 10.3% | -9.0% | -46.9% | 135.8% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 2.8% | -18.9% | 4.4% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 6.3% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 2.1% | 11.6% | -8.9% | -46.3% | 129.9% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 1.3% | -18.2% | 4.0% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 5.1% | · | · | · | · | · | · | · | · | · | · | · |
Valutazione (TTM) 17
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $14.34B | $14.20B | $13.12B | $12.17B | $16.07B | $8.50B | $6.56B | $5.15B | $5.87B | $4.86B | $4.10B | $2.82B | |
| Net Income TTM | $4.50B | $4.41B | $3.95B | $4.34B | $8.08B | $3.51B | $2.12B | $2.44B | $1.20B | $896M | $636M | $338M | |
| Market Cap | $106.21B | $96.88B | $116.90B | $94.08B | · | · | · | · | · | · | · | · | |
| Enterprise Value | $99.59B | $89.85B | $108.04B | $88.32B | · | · | · | · | · | · | · | · | |
| P/E | 18.6 | 18.6 | 25.3 | 18.9 | 8.8 | 15.8 | 20.3 | 17.5 | 36.4 | 47.7 | 98.3 | 137.7 | |
| P/S | 7.4 | 6.8 | 8.9 | 7.7 | · | · | · | · | · | · | · | · | |
| P/B | 3.4 | 3.3 | 4.5 | 4.2 | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 3.5 | 3.4 | 4.7 | 4.3 | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 21.3 | 21.9 | 25.4 | 18.8 | · | · | · | · | · | · | · | · | |
| P / FCF | 26.0 | 26.4 | 30.2 | 21.3 | · | · | · | · | · | · | · | · | |
| EV / EBITDA | 24.2 | 20.1 | 24.2 | 17.4 | · | · | · | · | · | · | · | · | |
| EV / FCF | 24.4 | 24.5 | 27.9 | 20.0 | · | · | · | · | · | · | · | · | |
| EV / Revenue | 6.9 | 6.3 | 8.2 | 7.3 | · | · | · | · | · | · | · | · | |
| Dividend Yield | 0.35% | 0.00% | 0.00% | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | 5.4% | 5.4% | 4.0% | 5.3% | 11.4% | 6.3% | 4.9% | 5.7% | 2.8% | 2.1% | 1.0% | 0.73% | |
| Payout Ratio | 8.2% | · | · | · | · | · | · | · | · | · | · | · | |
| Annual Payout | $370M | $0 | $0 | · | · | · | · | · | · | · | · | · |
Conto Economico 15
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.29B | $3.61B | $3.88B | $3.75B | $3.68B | $3.03B | $3.79B | $3.72B | $3.55B | $3.15B | $3.43B | $3.36B | $3.16B | $3.16B | $3.41B | $2.94B | |
| R&D Expense | $1.63B | $1.54B | $1.63B | $1.48B | $1.42B | $1.33B | $1.41B | $1.27B | $1.20B | $1.25B | $1.18B | $1.08B | $1.09B | $1.10B | $1.04B | $911M | |
| SG&A Expense | $662M | $648M | $775M | $658M | $634M | $633M | $792M | $714M | $759M | $689M | $738M | $640M | $652M | $601M | $660M | $529M | |
| Operating Expenses | $3.00B | $2.96B | $3.00B | $2.73B | $2.60B | $2.44B | $2.80B | $2.54B | $2.48B | $2.39B | $2.46B | $2.25B | $2.14B | $2.22B | $2.27B | $1.71B | |
| Operating Income | $1.29B | $643M | $880M | $1.03B | $1.08B | $592M | $990M | $1.18B | $1.07B | $751M | $973M | $1.11B | $1.02B | $947M | $1.15B | $1.22B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $16M | · | $18M | $19M | $18M | · | $15M | |
| Other Non-op | $245M | $201M | $176M | $756M | $443M | $322M | $-22M | $327M | $573M | $-35M | $193M | $18M | $85M | $-71M | $195M | $301M | |
| Pretax Income | $1.53B | $831M | $1.04B | $1.76B | $1.52B | $905M | $958M | $1.49B | $1.63B | $701M | $1.15B | $1.11B | $1.08B | $858M | $1.32B | $1.51B | |
| Income Tax | $231M | $104M | $199M | $303M | $127M | $96M | $40M | $152M | $196M | $-21M | $-12M | $103M | $114M | $40M | $128M | $194M | |
| Net Income | $1.30B | $727M | $845M | $1.46B | $1.39B | $809M | $918M | $1.34B | $1.43B | $722M | $1.16B | $1.01B | $968M | $818M | $1.20B | $1.32B | |
| EPS (Basic) | $12.62 | $6.99 | $8.16 | $14.09 | $13.24 | $7.58 | $8.55 | $12.40 | $13.25 | $6.70 | $10.88 | $9.48 | $9.05 | $7.64 | $11.18 | $12.31 | |
| EPS (Diluted) | $12.23 | $6.75 | $7.78 | $13.62 | $12.81 | $7.27 | $8.12 | $11.54 | $12.41 | $6.27 | $10.21 | $8.89 | $8.50 | $7.17 | $10.48 | $11.66 | |
| Shares (Basic) | 102,800,000 | 104,000,000 | -210,800,000 | 103,600,000 | 105,100,000 | 106,700,000 | -216,100,000 | 108,100,000 | 108,100,000 | 107,800,000 | -213,700,000 | 106,300,000 | 107,000,000 | 107,100,000 | -214,500,000 | 106,900,000 | |
| Shares (Diluted) | 106,000,000 | 107,700,000 | -218,400,000 | 107,200,000 | 108,600,000 | 111,200,000 | -231,600,000 | 116,200,000 | 115,400,000 | 115,100,000 | -227,600,000 | 113,400,000 | 113,900,000 | 114,000,000 | -226,400,000 | 112,800,000 | |
| EBITDA | $1.29B | $766M | · | $1.03B | $1.08B | $719M | · | $1.18B | $1.07B | $866M | · | $1.11B | $1.02B | $1.05B | · | $1.22B |
Stato Patrimoniale 24
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.46B | $2.96B | $3.12B | $2.51B | $2.00B | $3.09B | $2.49B | $2.01B | $1.92B | $2.60B | $2.73B | $2.15B | $1.94B | $3.92B | $3.11B | $3.49B | |
| Short-term Investments | $5.54B | $5.79B | $5.49B | $5.94B | $5.47B | $5.26B | $6.52B | $7.78B | $7.89B | $7.92B | · | $7.76B | $6.99B | $5.04B | · | $3.53B | |
| Receivables | $6.57B | $5.73B | $5.74B | $5.69B | $5.61B | $5.56B | $6.21B | $6.11B | $5.72B | $5.22B | · | $5.58B | $5.12B | $5.12B | · | $5.55B | |
| Inventory | $3.08B | $3.10B | $3.20B | $3.25B | $3.21B | $3.19B | $3.09B | $3.02B | $2.87B | $2.71B | · | $2.56B | $2.51B | $2.42B | · | $2.41B | |
| Prepaid Expense | $802M | $621M | $475M | $596M | $574M | $469M | $349M | $412M | $682M | $415M | · | $575M | $366M | $406M | · | $446M | |
| Current Assets | $18.45B | $18.21B | $18.02B | $17.98B | $16.86B | $17.57B | $18.66B | $19.33B | $19.08B | $18.87B | · | $18.63B | $16.92B | $16.91B | · | $15.43B | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $3.70B | |
| Intangibles | $1.31B | $1.29B | $1.26B | $1.38B | $1.35B | $1.17B | $1.15B | $1.12B | $1.10B | $1.06B | · | $1.02B | $953M | $929M | · | $804M | |
| Other Non-current Assets | $2.31B | $2.13B | $1.82B | $1.67B | $1.54B | $1.39B | $1.14B | $1.04B | $994M | $470M | · | $410M | $393M | $350M | · | $320M | |
| Total Assets | $41.73B | $40.87B | $40.56B | $40.17B | $38.22B | $37.55B | $37.76B | $37.44B | $36.09B | $34.37B | · | $32.16B | $30.66B | $30.06B | · | $27.68B | |
| Accounts Payable | $1.16B | $1.03B | $939M | $904M | $724M | $706M | $790M | $497M | $562M | $671M | · | $537M | $547M | $600M | · | · | |
| Current Liabilities | $5.53B | $5.11B | $4.37B | $4.43B | $3.67B | $3.57B | $3.94B | $3.66B | $3.51B | $3.58B | · | $3.60B | $3.10B | $3.10B | · | $2.88B | |
| Capital Leases | · | · | $229M | · | · | · | $204M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $2.28B | $2.13B | $2.02B | $1.86B | $1.70B | $1.67B | $1.57B | $1.54B | $1.46B | $908M | · | $832M | $717M | $677M | · | $599M | |
| Total Liabilities | $10.02B | $9.45B | $9.30B | $9.21B | $8.28B | $8.16B | $8.41B | $8.12B | $7.88B | $7.38B | · | $7.26B | $6.64B | $6.56B | · | $6.24B | |
| Total Debt | $1.99B | $1.99B | · | $1.99B | $1.99B | $1.98B | · | $1.98B | $1.98B | $1.98B | · | $1.98B | $1.98B | $1.98B | · | $1.98B | |
| Common Stock | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | · | $100.0K | $100.0K | $100.0K | · | $100.0K | |
| Paid-in Capital | $14.70B | $14.40B | $13.99B | $13.79B | $13.49B | $13.19B | $12.86B | $12.70B | $12.32B | $11.94B | · | $11.25B | $10.89B | $10.60B | · | $9.52B | |
| Retained Earnings | $37.62B | $36.42B | $35.80B | $35.05B | $33.68B | $32.38B | $31.67B | $30.76B | $29.41B | $27.98B | · | $26.10B | $25.09B | $24.12B | · | $22.11B | |
| Treasury Stock | $20.57B | $19.41B | $18.61B | $17.94B | $17.28B | $16.22B | $15.17B | $14.19B | $13.46B | $12.86B | · | $12.27B | $11.77B | $11.05B | · | $9.91B | |
| AOCI | $-36M | $12M | $78M | $69M | $52M | $29M | $-8M | $60M | $-70M | $-77M | · | $-177M | $-198M | $-182M | · | $-275M | |
| Stockholders' Equity | $31.71B | $31.42B | $31.26B | $30.96B | $29.94B | $29.39B | $29.35B | $29.33B | $28.21B | $26.99B | $25.97B | $24.90B | $24.02B | $23.50B | $22.66B | $21.44B | |
| Liabilities + Equity | $41.73B | $40.87B | $40.56B | $40.17B | $38.22B | $37.55B | $37.76B | $37.44B | $36.09B | $34.37B | · | $32.16B | $30.66B | $30.06B | · | $27.68B | |
| Shares Outstanding | 138,000,000 | 137,900,000 | 137,600,000 | 136,200,000 | 136,200,000 | 136,100,000 | 136,000,000 | 135,300,000 | 134,800,000 | 134,200,000 | 133,100,000 | 132,100,000 | 131,600,000 | 131,400,000 | 130,400,000 | 129,000,000 |
Flusso di cassa 15
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $124M | $123M | $145M | $137M | $135M | $127M | $126M | $122M | $121M | $114M | $113M | $105M | $103M | $100M | $100M | $93M | |
| Stock-based Comp | $243M | $257M | $249M | $237M | $252M | $256M | $304M | $225M | $223M | $230M | $240M | $204M | $202M | $239M | $232M | $166M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $21M | $16M | |
| Other Non-cash | · | $-29M | · | · | · | $-146M | · | · | · | $446M | · | · | · | $212M | · | · | |
| Operating Cash Flow | $813M | $1.08B | $1.17B | $1.62B | $1.14B | $1.05B | $1.26B | $1.29B | $354M | $1.51B | $1.09B | $1.11B | $1.02B | $1.37B | $1.72B | $629M | |
| CapEx | $240M | $231M | $249M | $201M | $219M | $229M | $200M | $242M | $180M | $134M | $251M | $176M | $113M | $178M | $152M | $142M | |
| Investing Cash Flow | $-93M | $-429M | $220M | $-403M | $-1.09B | $648M | $351M | $-574M | $-557M | $-1.69B | $-66M | $-496M | $-2.39B | $-236M | $-1.86B | $192M | |
| Stock Issued | $49M | $163M | $504M | $40M | $32M | $61M | $91M | $255M | $438M | $682M | $301M | $269M | $91M | $485M | $373M | $318M | |
| Stock Repurchased | $1.17B | $794M | $672M | $664M | $1.06B | $1.04B | $973M | $735M | $604M | $291M | $289M | $546M | $689M | $711M | $431M | $935M | |
| Net Stock Activity | · | $-631M | · | · | · | $-981M | · | · | · | $391M | · | · | · | $-226M | · | · | |
| Dividends Paid | $97M | $98M | $93M | $91M | $93M | $94M | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Financing Cash Flow | $-1.22B | $-802M | $-780M | $-718M | $-1.13B | $-1.09B | $-1.14B | $-634M | $-478M | $47M | $-446M | $-407M | $-614M | $-322M | $-248M | $-725M | |
| Net Change in Cash | $-505M | $-153M | $611M | $498M | $-1.08B | $604M | $477M | $84M | $-682M | $-128M | $578M | $210M | $-1.98B | $809M | $-385M | $96M | |
| Free Cash Flow | · | $848M | · | · | · | $816M | · | · | · | $1.38B | · | · | · | $1.19B | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $1.36B | · | · | · | $1.17B | · | · |
Redditività 7
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 30.1% | 17.8% | · | 27.4% | 29.4% | 19.5% | · | 31.7% | 30.1% | 23.9% | · | 33.0% | 32.2% | 29.9% | · | 41.7% | |
| Net Margin | 30.2% | 20.2% | · | 38.9% | 37.9% | 26.7% | · | 36.0% | 40.4% | 23.0% | · | 30.0% | 30.7% | 25.9% | · | 44.8% | |
| Pretax Margin | 35.6% | 23.1% | · | 47.0% | 41.3% | 29.9% | · | 40.1% | 45.9% | 22.3% | · | 33.0% | 34.3% | 27.1% | · | 51.4% | |
| EBITDA Margin | 30.1% | 21.2% | · | 27.4% | 29.4% | 23.7% | · | 31.7% | 30.1% | 27.5% | · | 33.0% | 32.2% | 33.1% | · | 41.7% | |
| ROA | 3.2% | 1.8% | · | 3.8% | 3.8% | 2.2% | · | 3.9% | 4.3% | 2.2% | · | 3.4% | 3.4% | 2.9% | · | 5.1% | |
| ROE | 4.2% | 2.4% | · | 4.8% | 4.8% | 2.9% | · | 4.9% | 5.5% | 2.9% | · | 4.3% | 4.3% | 3.8% | · | 6.8% | |
| ROIC | 3.3% | 1.7% | · | 2.6% | 3.1% | 1.7% | · | 3.4% | 3.1% | 2.7% | · | 3.8% | 3.5% | 3.5% | · | 4.5% |
Liquidità e Solvibilità 5
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.3 | 3.6 | · | 4.1 | 4.6 | 4.9 | · | 5.3 | 5.4 | 5.3 | · | 5.2 | 5.5 | 5.5 | · | 5.4 | |
| Quick Ratio | 2.6 | 2.8 | · | 3.2 | 3.6 | 3.9 | · | 4.3 | 4.4 | 4.4 | · | 4.3 | 4.5 | 4.5 | · | 4.4 | |
| Debt / Equity | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| LT Debt / Equity | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 46.7 | · | 62.4 | 53.8 | 52.6 | · | 80.0 |
Efficienza 2
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 0.7 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | 0.7 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.5 |
Valutazione (TTM) 15
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $15.33B | $14.06B | · | $14.18B | $13.97B | $13.44B | · | $13.78B | $13.21B | $12.83B | · | $12.62B | $12.11B | $11.92B | · | $12.21B | |
| Net Income TTM | $4.88B | $4.39B | · | $5.00B | $4.97B | $4.30B | · | $4.50B | $4.13B | $3.52B | · | $4.11B | $3.95B | $3.96B | · | $4.77B | |
| Market Cap | $86.05B | $106.55B | · | $76.58B | $71.50B | $86.32B | · | $142.23B | $141.68B | $129.17B | · | $108.71B | $94.56B | $107.97B | · | $88.86B | |
| Enterprise Value | $80.04B | $99.78B | · | $70.12B | $66.02B | $79.95B | · | $134.42B | $133.85B | $120.63B | · | $100.78B | $87.61B | $100.99B | · | $83.82B | |
| P/E | 13.7 | 19.1 | · | 12.4 | 11.9 | 16.9 | · | 26.9 | 29.1 | 31.2 | · | 22.7 | 20.6 | 23.5 | · | 16.4 | |
| P/S | 5.6 | 7.6 | · | 5.4 | 5.1 | 6.4 | · | 10.3 | 10.7 | 10.1 | · | 8.6 | 7.8 | 9.1 | · | 7.3 | |
| P/B | 2.7 | 3.4 | · | 2.5 | 2.4 | 2.9 | · | 4.9 | 5.0 | 4.8 | · | 4.4 | 3.9 | 4.6 | · | 4.1 | |
| P / Tangible Book | 2.8 | 3.5 | · | 2.6 | 2.5 | 3.1 | · | 5.0 | 5.2 | 5.0 | · | 4.6 | 4.1 | 4.8 | · | 4.3 | |
| P / Cash Flow | · | 98.8 | · | · | · | 82.6 | · | · | · | 85.4 | · | · | · | 78.9 | · | · | |
| P / FCF | · | 125.6 | · | · | · | 105.8 | · | · | · | 93.7 | · | · | · | 90.8 | · | · | |
| EV / EBITDA | 61.9 | 130.2 | · | 68.3 | 61.2 | 111.3 | · | 114.0 | 125.1 | 139.4 | · | 90.7 | 86.2 | 96.5 | · | 68.5 | |
| EV / FCF | · | 117.6 | · | · | · | 98.0 | · | · | · | 87.5 | · | · | · | 84.9 | · | · | |
| EV / Revenue | 5.2 | 7.1 | · | 4.9 | 4.7 | 5.9 | · | 9.8 | 10.1 | 9.4 | · | 8.0 | 7.2 | 8.5 | · | 6.9 | |
| Earnings Yield | 7.3% | 5.2% | · | 8.1% | 8.4% | 5.9% | · | 3.7% | 3.4% | 3.2% | · | 4.4% | 4.8% | 4.2% | · | 6.1% | |
| Payout Ratio | · | 13.5% | · | · | · | 11.6% | · | · | · | · | · | · | · | · | · | · |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ricavi | $14.34B | $14.20B | $13.12B | $12.17B | $16.07B |
| Margine Operativo % | 24.9% | 28.1% | 30.9% | 38.9% | 55.7% |
| Utile netto | $4.50B | $4.41B | $3.95B | $4.34B | $8.08B |
| EPS Diluito | $41.48 | $38.34 | $34.77 | $38.22 | $71.97 |
Stato Patrimoniale
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Rapporto corrente | 4.1 | 4.7 | 5.7 | 5.1 | 3.6 |
| Quick Ratio | 3.3 | 3.9 | 4.8 | 4.2 | 3.0 |
Flusso di cassa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flusso di cassa libero | $4.08B | $3.66B | $3.88B | $4.42B | $6.53B |
Ultime notizie Notizie recenti che menzionano questa società
- Potenziale di guadagno del 20% implicito nelle partecipazioni di FDG
- iShares MSCI USA Min Vol Factor ETF Sperimenta un Grande Deflusso
- Regeneron Pharmaceuticals (REGN) Annuncia la Collaborazione con Telix Pharmaceuticals Limited
- Anteprima degli utili: cosa aspettarsi dal rapporto di Regeneron Pharmaceuticals
- Regeneron Pharma stringe una partnership con Telix Pharma per sviluppare congiuntamente terapie radi farmaceutiche
- Jim Cramer su Regeneron (REGN): 'Penso che il titolo stia rompendo qui'
- Telix e Regeneron Collaborano per Sviluppare Terapie Radi farmaceutiche di Prossima Generazione
- Formycon Assicura Tempi di Lancio Europei per FYB203 Dopo Accordo Regeneron, Bayer
- Regeneron Pharmaceuticals, Inc. (REGN) è un buon titolo da comprare?
Segnali di trading Segnali recenti di acquisto/vendita con prezzo di entrata e rapporto rischio/rendimento
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Proprietari istituzionali (13F) 1.481 filer · $34.8B totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 124 (-35 vs trimestre precedente) | 162 (+63 vs trimestre precedente) | 481 (-68 vs trimestre precedente) | 526 (+45 vs trimestre precedente) | +9.2M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $4.133.919.926 | 6.629.759 | 11,89% | Azioni |
| Dodge & Cox | $3.037.348.765 | 4.871.137 | 8,73% | Azioni |
| STATE STREET CORP | $3.014.621.356 | 4.834.688 | 8,67% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.979.934.668 | 3.175.313 | 5,69% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $1.427.303.015 | 2.297.074 | 4,10% | Azioni |
| LOOMIS SAYLES & CO L P | $1.014.501.372 | 1.627.003 | 2,92% | Azioni |
| PeakShares LLC | $975.217.000 | 1.564 | 2,80% | Azioni |
| WELLINGTON MANAGEMENT GROUP LLP | $763.126.911 | 1.223.862 | 2,19% | Azioni |
| NORGES BANK | $731.292.700 | 1.172.808 | 2,10% | Azioni |
| Capital World Investors | $508.138.359 | 814.925 | 1,46% | Azioni |
| TWO SIGMA ADVISERS, LP | $466.626.290 | 604.540 | 1,34% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $432.674.406 | 693.900 | 1,24% | Opzione Put |
| TWO SIGMA INVESTMENTS, LP | $409.119.559 | 656.124 | 1,18% | Azioni |
| GOLDMAN SACHS GROUP INC | $392.576.914 | 629.594 | 1,13% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $351.496.357 | 563.711 | 1,01% | Azioni |
| FIRST TRUST ADVISORS LP | $341.158.711 | 547.132 | 0,98% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $299.532.285 | 480.373 | 0,86% | Azioni |
| Robeco Institutional Asset Management B.V. | $287.203.770 | 460.602 | 0,83% | Azioni |
| NEUBERGER BERMAN GROUP LLC | $259.935.179 | 416.870 | 0,75% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $249.320.598 | 399.847 | 0,72% | Azioni |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $245.478.345 | 393.685 | 0,71% | Azioni |
| National Pension Service | $236.829.845 | 379.815 | 0,68% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $236.259.306 | 378.900 | 0,68% | Opzione Call |
| ALLIANCEBERNSTEIN L.P. | $225.872.032 | 292.338 | 0,65% | Azioni |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $220.714.454 | 353.970 | 0,63% | Azioni |
| BlackRock, Inc. | $207.677.479 | 333.062 | 0,60% | Azioni |
| JANE STREET GROUP, LLC | $198.659.844 | 318.600 | 0,57% | Opzione Call |
| Swiss National Bank | $182.709.691 | 293.020 | 0,53% | Azioni |
| Sumitomo Mitsui Trust Group, Inc. | $175.962.364 | 282.199 | 0,51% | Azioni |
| BANK OF AMERICA CORP /DE/ | $171.791.505 | 275.510 | 0,49% | Azioni |
| CITADEL ADVISORS LLC | $169.166.402 | 271.300 | 0,49% | Opzione Call |
| FIL Ltd | $165.543.635 | 265.490 | 0,48% | Azioni |
| CITADEL ADVISORS LLC | $164.988.684 | 264.600 | 0,47% | Opzione Put |
| FMR LLC | $162.474.852 | 260.568 | 0,47% | Azioni |
| TD Asset Management Inc | $161.694.522 | 259.317 | 0,46% | Azioni |
| Mitsubishi UFJ Asset Management Co., Ltd. | $160.530.373 | 257.450 | 0,46% | Azioni |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $159.939.881 | 256.503 | 0,46% | Azioni |
| Nuveen, LLC | $158.965.911 | 254.941 | 0,46% | Azioni |
| Caisse de depot et placement du Quebec | $156.264.112 | 250.608 | 0,45% | Azioni |
| Assenagon Asset Management S.A. | $152.721.782 | 244.927 | 0,44% | Azioni |
| Vanguard Global Advisers, LLC | $141.371.483 | 226.724 | 0,41% | Azioni |
| California Public Employees Retirement System | $139.840.692 | 224.269 | 0,40% | Azioni |
| Qube Research & Technologies Ltd | $138.180.829 | 221.607 | 0,40% | Azioni |
| Legal & General Group Plc | $134.385.341 | 215.520 | 0,39% | Azioni |
| CANADA PENSION PLAN INVESTMENT BOARD | $130.887.905 | 209.911 | 0,38% | Azioni |
| Squarepoint Ops LLC | $123.814.467 | 198.567 | 0,36% | Azioni |
| VANGUARD ASSET MANAGEMENT, Ltd | $123.317.506 | 197.770 | 0,35% | Azioni |
| Candriam S.C.A. | $121.893.176 | 195.674 | 0,35% | Azioni |
| MCDONALD CAPITAL INVESTORS INC/CA | $120.366.915 | 193.038 | 0,35% | Azioni |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $119.141.861 | 154.201 | 0,34% | Azioni |
| Swedbank AB | $118.377.821 | 189.848 | 0,34% | Azioni |
| Carmignac Gestion | $113.826.706 | 182.507 | 0,33% | Azioni |
| BANK OF NOVA SCOTIA | $113.300.959 | 181.706 | 0,33% | Azioni |
| JANE STREET GROUP, LLC | $112.548.970 | 180.500 | 0,32% | Opzione Put |
| BARCLAYS PLC | $111.306.254 | 178.507 | 0,32% | Azioni |
| PANAGORA ASSET MANAGEMENT INC | $109.300.950 | 175.291 | 0,31% | Azioni |
| GOLDMAN SACHS GROUP INC | $106.687.694 | 171.100 | 0,31% | Opzione Call |
| MILLENNIUM MANAGEMENT LLC | $102.958.925 | 165.120 | 0,30% | Azioni |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $102.237.489 | 163.963 | 0,29% | Azioni |
| Bronte Capital Management Pty Ltd. | $101.398.828 | 162.618 | 0,29% | Azioni |
| NORDEA INVESTMENT MANAGEMENT AB | $100.247.789 | 160.258 | 0,29% | Azioni |
| RAYMOND JAMES FINANCIAL INC | $99.201.835 | 159.095 | 0,29% | Azioni |
| RHUMBLINE ADVISERS | $98.390.781 | 157.794 | 0,28% | Azioni |
| Pictet Asset Management Holding SA | $96.459.212 | 153.500 | 0,28% | Azioni |
| RENAISSANCE TECHNOLOGIES LLC | $92.422.346 | 148.222 | 0,27% | Azioni |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $92.259.602 | 147.961 | 0,27% | Azioni |
| AMERIPRISE FINANCIAL INC | $90.305.429 | 144.827 | 0,26% | Azioni |
| MACKENZIE FINANCIAL CORP | $84.666.132 | 135.783 | 0,24% | Azioni |
| PRUDENTIAL FINANCIAL INC | $81.380.076 | 130.513 | 0,23% | Azioni |
| Retirement Systems of Alabama | $79.731.436 | 127.869 | 0,23% | Azioni |
| MARSHALL WACE, LLP | $79.189.580 | 127.000 | 0,23% | Opzione Put |
| Sound Shore Management Inc /CT/ | $79.185.839 | 126.994 | 0,23% | Azioni |
| VICTORY CAPITAL MANAGEMENT INC | $78.779.916 | 126.343 | 0,23% | Azioni |
| ProShare Advisors LLC | $74.350.910 | 119.240 | 0,21% | Azioni |
| NEW YORK STATE COMMON RETIREMENT FUND | $69.443.026 | 111.369 | 0,20% | Azioni |
| ENVESTNET ASSET MANAGEMENT INC | $68.488.193 | 109.838 | 0,20% | Azioni |
| Gotham Asset Management, LLC | $65.574.584 | 105.165 | 0,19% | Azioni |
| Harvest Portfolios Group Inc. | $65.232.261 | 104.616 | 0,19% | Azioni |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $62.737.149 | 100.286 | 0,18% | Azioni |
| Mariner, LLC | $61.632.002 | 98.826 | 0,18% | Azioni |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $61.471.693 | 98.585 | 0,18% | Azioni |
| PARNASSUS INVESTMENTS, LLC | $59.471.998 | 95.378 | 0,17% | Azioni |
| Davern Capital Partners, LP | $57.764.746 | 92.640 | 0,17% | Azioni |
| AVIVA PLC | $57.045.180 | 91.486 | 0,16% | Azioni |
| PFA Pension, Forsikringsaktieselskab | $56.561.245 | 90.710 | 0,16% | Azioni |
| ARMISTICE CAPITAL, LLC | $55.999.504 | 89.809 | 0,16% | Azioni |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $54.996.852 | 88.201 | 0,16% | Azioni |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $52.429.737 | 84.084 | 0,15% | Azioni |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $52.158.497 | 83.649 | 0,15% | Azioni |
| ROYAL BANK OF CANADA | $51.450.000 | 82.513 | 0,15% | Azioni |
| CWM, LLC | $51.303.491 | 66.400 | 0,15% | Azioni |
| PINNACLE ASSOCIATES LTD | $50.660.926 | 81.247 | 0,15% | Azioni |
| GROUPAMA ASSET MANAGMENT | $49.128.285 | 77.940 | 0,14% | Azioni |
| NEOS Investment Management LLC | $48.213.359 | 77.322 | 0,14% | Azioni |
| CAPITOLIS LIQUID GLOBAL MARKETS LLC | $46.765.500 | 75.000 | 0,13% | Azioni |
| Korea Investment CORP | $46.737.441 | 74.955 | 0,13% | Azioni |
| Grantham, Mayo, Van Otterloo & Co. LLC | $46.266.668 | 74.200 | 0,13% | Azioni |
| WOLVERINE TRADING, LLC | $45.925.425 | 81.900 | 0,13% | Opzione Call |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $45.875.500 | 59.375 | 0,13% | Azioni |
| Woodline Partners LP | $45.265.886 | 72.595 | 0,13% | Azioni |
Insider aziendali 39 insider · 3 dirigenti · 7 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Leonard S Schleifer | Bd. Co-Chair, President & CEO | 31 Dicembre 2025 M | 214.523 | 0 | 0 | $0 |
| Christopher R. Fenimore | SVP Controller | 20 Agosto 2021 F | 19.020 | 0 | 0 | $0 |
| Van Plew Daniel P | EVP & General Mgr Industrial O | 20 Agosto 2020 M | 47.110 | 0 | 0 | $0 |
| Arthur F Ryan | Direttore | 02 Luglio 2026 S | 17.303 | 0 | 48 | $-434.683 |
| Anthony N Coles | Direttore | 02 Gennaio 2026 A | 1.714 | 0 | 0 | $0 |
| Christine A Poon | Direttore | 02 Gennaio 2026 A | 5.219 | 0 | 6 | $-4.252.745 |
| Michael S Brown | Direttore | 02 Gennaio 2026 A | 1.703 | 0 | 0 | $0 |
| David P Schenkein | Direttore | 08 Settembre 2023 A | 240 | 0 | 0 | $0 |
| Craig B. Thompson | Direttore | 03 Ottobre 2022 A | 279 | 0 | 0 | $0 |
| REGENERON PHARMACEUTICALS, INC. | Proprietario del 10% | 17 Febbraio 2021 C | 2.097.314 | 0 | 0 | $0 |
| Sanofi | Proprietario del 10% | 09 Giugno 2020 S | 279.766 | 0 | 0 | $0 |
| Pharma Ag Novartis | Proprietario del 10% | 08 Novembre 2005 S | — | 0 | 0 | $0 |
| Kathryn Guarini | — | 10 Agosto 2026 M | 603 | 0 | 1 | $-320.000 |
| Huda Y Zoghbi | — | 10 Agosto 2026 M | 1.703 | 0 | 1 | $-640.000 |
| Joseph L Goldstein | — | 02 Gennaio 2026 A | 6.703 | 0 | 0 | $0 |
| George L Sing | — | 02 Gennaio 2026 A | 31.007 | 0 | 0 | $0 |
| George Yancopoulos | — | 31 Dicembre 2025 M | 310.460 | 0 | 0 | $0 |
| Joseph J Larosa | — | 05 Dicembre 2025 A | 29.517 | 0 | 0 | $0 |
| Marc Tessier-Lavigne | — | 09 Dicembre 2021 M | 2.078 | 0 | 0 | $0 |
| Marion Mccourt | — | 07 Giugno 2021 M | 17.038 | 0 | 0 | $0 |
| Andrew J Murphy | — | 09 Dicembre 2020 A | 57.350 | 0 | 0 | $0 |
| Robert E Landry | — | 09 Dicembre 2020 A | 25.903 | 0 | 0 | $0 |
| Neil Stahl | — | 09 Dicembre 2020 A | 24.715 | 0 | 0 | $0 |
| Bonnie L Bassler | — | 19 Giugno 2020 M | 643 | 0 | 0 | $0 |
| VAGELOS P ROY | — | 16 Dicembre 2019 I | 2.200 | 0 | 0 | $0 |
| Charles A Baker | — | 02 Gennaio 2018 A | 9.000 | 0 | 0 | $0 |
| Robert J Terifay | — | 12 Dicembre 2017 A | 23.293 | 0 | 0 | $0 |
| Michael S Aberman | — | 16 Dicembre 2016 A | 16.498 | 0 | 0 | $0 |
| Peter Powchik | — | 16 Dicembre 2016 A | 2.459 | 0 | 0 | $0 |
| Douglas S Mccorkle | — | 29 Dicembre 2015 M | 6.866 | 0 | 0 | $0 |
| Alfred G Gilman | — | 06 Agosto 2015 M | 8.912 | 0 | 0 | $0 |
| Robert Alexander Ingram | — | 22 Maggio 2015 M | 1.500 | 0 | 0 | $0 |
| Murray A Goldberg | — | 16 Dicembre 2014 A | 64.436 | 0 | 0 | $0 |
| Eric M Shooter | — | 12 Febbraio 2014 M | 0 | 0 | 0 | $0 |
| William Roberts | — | 18 Settembre 2013 M | 13.447 | 0 | 0 | $0 |
| Stuart Kolinski | — | 03 Giugno 2010 M | 16.329 | 0 | 0 | $0 |
| Peter Dworkin | — | 18 Dicembre 2009 A | — | 0 | 0 | $0 |
| Randall Rupp | — | 13 Aprile 2007 M | 3.983 | 0 | 0 | $0 |
| Hans Peter Guler | — | 08 Ottobre 2004 M | 10.530 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Attivisti e proprietari del 5%+ 2 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC., SYMPHONY ACQUISITION SUB, INC. ×2 depositi | 27 Settembre 2023 | — | Deposito iniziale | — | SEC |
| Sanofi ×17 depositi | 17 Giugno 2020 | — | Deposito iniziale | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Proprietà ETF Posseduti da 237 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| TBXU · Direxion Shares ETF Trust | 8,55% | 357 NS | 30 Aprile 2026 | N-PORT |
| IBB · iShares Trust | 6,00% | 740.981 SH | 08 Agosto 2026 | Giornaliero |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 5,51% | 5.609 SH | 08 Agosto 2026 | Giornaliero |
| PBE · Invesco Exchange-Traded Fund Trust | 5,42% | 25.033 SH | 08 Agosto 2026 | Giornaliero |
| IDNA · iShares Trust | 4,25% | 10.887 SH | 08 Agosto 2026 | Giornaliero |
| BIB · ProShares Trust | 3,21% | 3.840 NS | 31 Maggio 2026 | N-PORT |
| PJP · Invesco Exchange-Traded Fund Trust | 3,14% | 20.280 SH | 08 Agosto 2026 | Giornaliero |
| QQQA · ProShares Trust | 2,93% | 2.168 NS | 31 Maggio 2026 | N-PORT |
| AGNG · Global X Funds | 2,48% | 3.299 NS | 31 Maggio 2026 | N-PORT |
| SDG · iShares Trust | 2,28% | 5.119 SH | 08 Agosto 2026 | Giornaliero |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 2,19% | 344 NS | 30 Aprile 2026 | N-PORT |
| QQQG · Pacer Funds Trust | 2,18% | 348 NS | 30 Aprile 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,98% | 24.491 NS | 30 Aprile 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,98% | 19.712 SH | 08 Agosto 2026 | Giornaliero |
| SGLC · RBB Fund, Inc. | 1,87% | 5.922 NS | 31 Maggio 2026 | N-PORT |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,78% | 1.346 NS | 30 Aprile 2026 | N-PORT |
| HRTS · Tema ETF Trust | 1,67% | 1.408 NS | 31 Maggio 2026 | N-PORT |
| PWV · Invesco Exchange-Traded Fund Trust | 1,64% | 37.398 SH | 08 Agosto 2026 | Giornaliero |
| TECB · iShares Trust | 1,60% | 9.957 SH | 08 Agosto 2026 | Giornaliero |
| BBP · ETFis Series Trust I | 1,52% | 1.276 NS | 30 Aprile 2026 | N-PORT |
| QNXT · iShares Trust | 1,48% | 539 SH | 08 Agosto 2026 | Giornaliero |
| RILA · Spinnaker ETF Series | 1,44% | 854 NS | 30 Aprile 2026 | N-PORT |
| COWG · Pacer Funds Trust | 1,40% | 43.095 NS | 30 Aprile 2026 | N-PORT |
| FLAG · Global X Funds | 1,29% | 30 NS | 30 Aprile 2026 | N-PORT |
| IYH · iShares Trust | 1,27% | 60.521 SH | 08 Agosto 2026 | Giornaliero |
| NUGO · Nushares ETF Trust | 1,27% | 50.872 NS | 30 Aprile 2026 | N-PORT |
| GMOV · GMO ETF Trust | 1,19% | 1.758 NS | 31 Maggio 2026 | N-PORT |
| FCPI · FIDELITY COVINGTON TRUST | 1,19% | 4.569 NS | 30 Aprile 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 1,18% | 47.616 NS | 30 Aprile 2026 | N-PORT |
| COWZ · Pacer Funds Trust | 1,17% | 299.615 NS | 30 Aprile 2026 | N-PORT |
| QQWZ · Pacer Funds Trust | 1,16% | 770 NS | 30 Aprile 2026 | N-PORT |
| IMCV · iShares Trust | 1,08% | 16.108 SH | 08 Agosto 2026 | Giornaliero |
| CURE · Direxion Shares ETF Trust | 1,03% | 2.010 NS | 30 Aprile 2026 | N-PORT |
| HEQQ · J.P. Morgan Exchange-Traded Fund Tr… | 0,99% | 444 NS | 30 Aprile 2026 | N-PORT |
| CVAR · ETF Opportunities Trust | 0,99% | 540 NS | 30 Aprile 2026 | N-PORT |
| IXJ · iShares Trust | 0,98% | 52.534 SH | 08 Agosto 2026 | Giornaliero |
| VHT · VANGUARD WORLD FUND | 0,95% | 312.338 SH | 08 Agosto 2026 | Giornaliero |
| FLCV · Federated Hermes ETF Trust | 0,90% | 1.412 NS | 31 Maggio 2026 | N-PORT |
| RXL · ProShares Trust | 0,90% | 1.051 NS | 31 Maggio 2026 | N-PORT |
| QQQE · Direxion Shares ETF Trust | 0,87% | 14.942 NS | 30 Aprile 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,85% | 6.267 NS | 30 Aprile 2026 | N-PORT |
| SPXD · DBX ETF Trust | 0,79% | 87 NS | 31 Maggio 2026 | N-PORT |
| TAX · EA Series Trust | 0,78% | 324 NS | 29 Maggio 2026 | N-PORT |
| QIDX · Spinnaker ETF Series | 0,77% | 419 NS | 30 Aprile 2026 | N-PORT |
| JOET · Virtus ETF Trust II | 0,75% | 2.512 NS | 30 Aprile 2026 | N-PORT |
| CANC · Tema ETF Trust | 0,75% | 2.138 NS | 31 Maggio 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0,73% | 8.277 SH | 08 Agosto 2026 | Giornaliero |
| FLRG · FIDELITY COVINGTON TRUST | 0,72% | 2.871 NS | 30 Aprile 2026 | N-PORT |
| PEXL · Pacer Funds Trust | 0,69% | 448 NS | 30 Aprile 2026 | N-PORT |
| FLCC · Federated Hermes ETF Trust | 0,69% | 1.360 NS | 31 Maggio 2026 | N-PORT |